PTC Therapeutics price target raised to $45 from $43 at Barclays
Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...
Business Insider4h
PTC Therapeutics Gains Buy Rating Following FDA Approval of Groundbreaking Gene Therapy Kebilidi
Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
FXStreet22h
USD/CAD Forecast and News
Read more details about the forecast. The USD/CAD will see diverging central bank policy as a key driver through 2024, and the correlation between the Canadian Dollar and Crude Oil is likely to ...
Indiatimes35m
PTC India Share Price
PTC India Ltd., incorporated in the year 1999, is a Small Cap company (having a market cap of Rs 5,059.37 Crore) operating in Power sector. PTC India Ltd. key Products/Revenue Segments include ...